A contemporary analysis of the Australian clinical and genetic landscape of spinal muscular atrophy: a registry based studyResearch in context

Lakshmi Balaji; Robin Forbes; Anita Cairns; Hugo Sampaio; Andrew J. Kornberg; Lauren Sanders; Phillipa Lamont; Christina Liang; Kristi J. Jones; Kristen Nowak; Cullen O'Gorman; Ian Woodcock; Nancy Briggs; Eppie M. Yiu; Michelle A. Farrar; Didu Kariyawasam

The Lancet Regional Health. Western Pacific (Dec 2024)

A contemporary analysis of the Australian clinical and genetic landscape of spinal muscular atrophy: a registry based studyResearch in context

Lakshmi Balaji,
Robin Forbes,
Anita Cairns,
Hugo Sampaio,
Andrew J. Kornberg,
Lauren Sanders,
Phillipa Lamont,
Christina Liang,
Kristi J. Jones,
Kristen Nowak,
Cullen O'Gorman,
Ian Woodcock,
Nancy Briggs,
Eppie M. Yiu,
Michelle A. Farrar,
Didu Kariyawasam

Affiliations

Lakshmi Balaji: Department of Neurology, Sydney Children's Hospital Randwick, NSW, Australia; Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine and Health, University of New South Wales, Sydney, NSW, Australia; Corresponding author. Department of Neurology, Sydney Children's Hospital Randwick, NSW, Australia.
Robin Forbes: Australian Neuromuscular Disease Registry, Neuroscience Research Group, Murdoch Children's Research Institute, Parkville, VIC, Australia
Anita Cairns: Queensland Children's Hospital, Brisbane, QLD, Australia
Hugo Sampaio: Department of Neurology, Sydney Children's Hospital Randwick, NSW, Australia
Andrew J. Kornberg: Department of Neurology, The Royal Children's Hospital Melbourne, Parkville, VIC, Australia
Lauren Sanders: The University of Melbourne, VIC, Australia; St Vincent's Hospital, Melbourne, VIC, Australia
Phillipa Lamont: Royal Perth Hospital, Perth, WA, Australia
Christina Liang: Royal North Shore Hospital, St Leonards, NSW, Australia
Kristi J. Jones: Discipline of Child and Adolescent Health, University of Sydney, Sydney, NSW, Australia; Children's Hospital at Westmead, Westmead, NSW, Australia
Kristen Nowak: University of Western Australia, Perth, WA, Australia
Cullen O'Gorman: Princess Alexandra Hospital, Brisbane, QLD, Australia; University of Queensland, Brisbane, QLD, Australia
Ian Woodcock: Department of Neurology, The Royal Children's Hospital Melbourne, Parkville, VIC, Australia
Nancy Briggs: Mark Wainwright Analytical Centre, University of New South Wales, Sydney, NSW, Australia
Eppie M. Yiu: Australian Neuromuscular Disease Registry, Neuroscience Research Group, Murdoch Children's Research Institute, Parkville, VIC, Australia; Department of Neurology, The Royal Children's Hospital Melbourne, Parkville, VIC, Australia; Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia
Michelle A. Farrar: Department of Neurology, Sydney Children's Hospital Randwick, NSW, Australia; Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine and Health, University of New South Wales, Sydney, NSW, Australia
Didu Kariyawasam: Department of Neurology, Sydney Children's Hospital Randwick, NSW, Australia; Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine and Health, University of New South Wales, Sydney, NSW, Australia

Journal volume & issue: Vol. 53
p. 101237

Abstract

Read online

Summary: Background: New paradigms of diagnosis and treatment have changed the neurodegenerative trajectory for individuals with spinal muscular atrophy (SMA). Registries are a critical tool to provide real-world data on treatment patterns, their effects and health care provision within this evolving paradigm of care. This study aimed to evaluate the phenotypic and genotypic landscape, treatment patterns and health impact of SMA in Australia through the national registry. Methods: This cross-sectional study investigated demographic, clinical and genetic information, sequelae of weakness, treatment patterns and patient-reported outcomes amongst individuals with SMA enrolled in the Australian Neuromuscular Disease Registry (ANMDR) from 1st January 2020 to 30th April 2023. Descriptive statistics were used for analysis and Chi-Squared or Fisher's exact tests for associations. Findings: 195 individuals with SMA enrolled into the ANMDR. 5/195 (2.6%) were deceased by censor date. Of (n = 190) individuals living with SMA, 104/190 (54.7%) were children. Minimum Australian prevalence was 0.73/100,000. SMN2 copies were inversely associated with phenotype in those with homozygous SMN1 deletions (p < 0.0001)). Treatment was utilised in 154/190 (81%) of the population, with 65/137 (47.6%) of individuals perceiving improvements with therapeutic intervention on Patient/Parent Global Impression of Improvement scale (p < 0.0001). Engagement with multidisciplinary care practitioners was significantly higher among children with SMA than adults (93% versus 12%, p < 0.0001). Interpretation: Despite diagnostic and therapeutic advances, mortality and the multi-systemic health impact of SMA continue to be experienced within the Australian population. Healthcare provision must align with patient-centred outcomes, adapting to meeting their changing but ongoing care requirements. The study identified the considerable unmet need for multidisciplinary care, not only for adults with SMA but also for the emerging cohort of treated children, emphasising the imperative for comprehensive healthcare provision to address their evolving needs. Funding: No funding was received for this study.

Published in The Lancet Regional Health. Western Pacific

ISSN: 2666-6065 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Medicine: Public aspects of medicine
Website: https://www.thelancet.com/journals/lanwpc/home

About the journal

Abstract

Keywords